# Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer

> **NCT03237507** · — · UNKNOWN · sponsor: **Harbin Medical University** · enrollment: 110 (estimated)

## Conditions studied

- Stage IV Gastric Cancer With Metastasis

## Interventions

- **DRUG:** S-1
- **DRUG:** oxaliplatin
- **DEVICE:** Hyperthermic Intraperitoneal
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT03237507
- **Lead sponsor:** Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2019-06-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2017-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03237507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03237507, "Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03237507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*